ArticleClinical and experimental nephrology2023

Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD).

Mai Seki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.